Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Pancreatic cancer
Stage/Subtype:  stage I pancreatic cancer
Country:  U.S.A.
Trial Type:  Treatment
Results 1-25 of 26 for your search:
Start Over
Surgery With or Without Intraperitoneal Drainage in Improving Complication Rate in Patients With Pancreatic Disease
Phase: Phase III
Type: Health services research, Treatment
Age: 18 and over
Trial IDs: H-28324, NCI-2012-01881, NCT01441492
Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study)
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: ABI-007-PANC-003, NCI-2014-00810, 2013-003398-91, NCT01964430
Gemcitabine Hydrochloride, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, and Erismodegib before Surgery in Treating Patients with Borderline Resectable Pancreatic Cancer
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: J1130, NCI-2012-00064, CIR00003888, LDE225XUS03T, NA_00047491, NA_00047491 / CIR00004443, NCT01431794
Vaccine Therapy and Cyclophosphamide in Treating Patients with Pancreatic Cancer
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: J09100, NCI-2010-01868, CIR00005394, NA_00031401, NCT01088789
Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: TRIO-TORI PA-01, NCI-2010-02190, NCT01234935
Stereotactic Radiosurgery in Treating Patients with Pancreatic Cancer That Has Been Removed by Surgery
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 10-123, NCI-2014-01951, NCI-2014-01140, NCT01357525
Proton or Photon Beam Radiation Therapy, Capecitabine, and Hydroxychloroquine in Treating Patients with Pancreatic Cancer That Can Be Removed by Surgery
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 11-073, NCI-2012-00148, NCT01494155
Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Patients with High-Risk Pancreatic Cancer That Can Be Removed by Surgery
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 2011-1208, NCI-2012-00571, NCT01560949
Combination Chemotherapy and Intensity-Modulated Radiation Therapy in Treating Patients with Pancreatic Cancer That May Be Removed by Surgery
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: UMCC 2011.007, NCI-2012-01916, HUM00047389, HUM 47389, NCT01661088
Combination Chemotherapy with or without Oregovomab Followed by Stereotactic Body Radiation Therapy and Nelfinavir Mesylate in Treating Patients with Locally Advanced Pancreatic Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 19 and over
Trial IDs: 441-13, NCI-2013-02273, NCI-2012-00835, NCI-2013-02118, NCT01959672
Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation With or Without Hydroxychloroquine Before Surgery in Treating Patients With Pancreatic Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: UPCI 13-074, NCI-2013-02230, NCT01978184
Gemcitabine Hydrochloride and Nab-Paclitaxel or mFOLFIRINOX with Stereotactic Body Radiation Therapy before Surgery in Treating Patients with Pancreatic Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: Over 18
Trial IDs: UPCI# 13-143, NCI-2014-02046, PRO13120167, NCT02241551
Gemcitabine Hydrochloride, Ascorbic Acid, and Radiation Therapy in Treating Patients with Pancreatic Cancer That Cannot Be Removed by Surgery
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 201310772, NCI-2014-00824, GAX-PAN-I, NCT01852890
Stereotactic Body Radiation Therapy and Capecitabine before Surgery in Treating Patients with Pancreatic Cancer That Can Be Removed by Surgery
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 19 and over
Trial IDs: RO-12210, NCI-2013-01347, 2013-0645, 2013-0645-CP004, NCT01918644
Radiation Therapy and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients with Pancreatic Cancer
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: UPCC 32213, NCI-2015-00393, 819437, NCI-2014-01794, NCT02207465
Gemcitabine Hydrochloride, Nab-Paclitaxel, Radiation Therapy, Sorafenib Tosylate, and Vorinostat in Treating Patients with Previously Untreated Pancreatic Cancer
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: MCC-12-07328, NCI-2015-00017, NCT02349867
Whipple at the Splenic Artery (WATSA)
Phase: No phase specified
Type: Treatment
Age: 18 to 69
Trial IDs: 201105335 (10-0767), NCI-2011-00264, NCT01155882
Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation before Surgery in Treating Patients with Localized Pancreatic Cancer
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 to 80
Trial IDs: 101826, NCI-2012-01628, CTO # 101826, MUSC CTO #: 101826, Pro00019035, NCT01783054
Stereotactic Body Radiation Therapy and Metformin Hydrochloride in Treating Patients with Borderline-Resectable or Locally-Advanced Pancreatic Cancer
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: CASE 4213, NCI-2014-01172, 039877, NCT02153450
Thunderbeat Device in Reducing Blood Loss in Patients with Pancreatic Cancer Undergoing Whipple Procedure
Phase: No phase specified
Type: Treatment
Age: 22 to 75
Trial IDs: 201311146, NCI-2014-01300, NCT02204124
PEGPH20 and Cetuximab before Surgery in Treating Patients with Pancreatic Cancer That Can Be Removed by Surgery
Phase: No phase specified
Type: Diagnostic, Treatment
Age: 18 and over
Trial IDs: 14-039, NCI-2014-01977, NCT02241187
Start Over